CCConcorde

Name

CCConcorde

Legal name

Centre de Coordination en Cancérologie

Website

https://ccconcorde.org

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Oncology Care Coordination

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Clinical Document & Data Exchange (C-CDA, CCD, Direct Messaging) (HLACABAI)

Keywords

• Cancer care coordination
• Multidisciplinary tumor boards
• Oncology care pathways
• Patient personalized care program
• Healthcare network coordination

Headquarters

HQ city

Levallois-Perret

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Others

Revenue model

1. Public Healthcare System Funding: As a public interest general purpose coordination structure (GCS), CCConcorde operates under the French healthcare system with institutional funding from member establishments and regional health agency (ARS) support. Revenue is derived from healthcare system reimbursements and institutional contributions rather than direct patient billing.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

CCConcorde is a Centre de Coordination en Cancérologie (3C) that organizes and quality-assures multidisciplinary cancer care across 10 member healthcare establishments in the Hauts-de-Seine Nord region of France. It runs RCP tumor-board meetings, designs and tracks personalized PPS care programs, operates the Dispositif d'Annonce patient pathway, coordinates clinical research activity, and distributes patient information resources on behalf of its member facilities.

Product overview

CCConcorde operates as a unified Cancer Coordination Center (Centre de Coordination en Cancérologie / 3C) rather than a platform with separate modules. The organization coordinates cancer care across 10 member healthcare establishments in the Hauts-de-Seine Nord region. Its core services include organizing multidisciplinary consultation meetings (RCP), deploying the regional Dossier Communiquant en Cancérologie (DCC) IT system, managing personalized care programs (PPS), providing patient information guides (Cancer Info), and facilitating clinical research. The center functions as an umbrella coordination body rather than a product company.

Differentiator

Problem solved

Functional benefit

Products and services

• Multidisciplinary Tumor Board Meetings (Réunions de Concertation Pluridisciplinaire, RCP)
• Personalized Care Program (Programme Personnalisé de Soins, PPS)
• Dispositif d'Annonce (Patient Announcement Device)
• Clinical Research Coordination
• Cancer Info Patient Information Guides

Quantifiable outcome

• ~50,000 patients treated annually across network
• +3 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core.

• Institut Rafaël - Maison de l'après cancercoreStrategic or Co-development Partner · 1 December 2018Unique post-cancer integrative care institute in Europe opened December 2018, providing free multidisciplinary support services (30 disciplines, 70 caregivers) for cancer patients during and after treatment. Dr. Alain Toledano serves as President of the institute and is also a CCConcorde practitioner.
• Institut National du Cancer (INCa)coreStrategic or Co-development PartnerCCConcorde operates under the regulatory framework established by INCa through the Plan Cancer (2003-2007, 2009-2013, 2014-2019). INCa defines the standards, quality criteria, and protocols that CCConcorde implements across its member establishments. The organization participates in the deployment of INCa-approved tools including the Dossier Communiquant en Cancérologie (DCC).
• Agence Régionale de Santé d'Île-de-France (ARS IDF)coreStrategic or Co-development PartnerRegional health agency that authorizes cancer care activities, delivers operational permits for radiation therapy and other cancer treatments, and oversees compliance with national cancer care standards. CCConcorde coordinates care within the ARS-defined territory of Hauts-de-Seine Nord.
• Haute Autorité de Santé (HAS)coreStrategic or Co-development PartnerNational health authority that certifies healthcare establishments. Member establishments undergo HAS certification audits. CCConcorde facilitates quality assurance and internal audit processes aligned with HAS standards across the network.
• ELSAN GroupcoreOthersCentre de Radiothérapie et de Radiochirurgie H. Hartmann is part of the ELSAN private hospital group. The radiation center operates on the site of Hôpital Franco-Britannique, providing integrated cancer care within the CCConcorde network.

Scale indicators7 records

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• Institut Curie: Leading French cancer research and treatment center operating multiple hospital and research sites in the Paris region; comparable as a multi-site oncology platform that participates in coordinated cancer care delivery and clinical research akin to CCConcorde's member establishments.
• ELSAN Group: Major French private hospital group; comparable because it owns Centre de Radiothérapie et de Radiochirurgie H. Hartmann, a CCConcorde member, and participates directly in the cancer care delivery that CCConcorde coordinates.
• Gustave Roussy: Largest comprehensive cancer center in France and Europe, located in the southern Paris suburbs; comparable as a major oncology delivery institution that engages with coordinated cancer pathways similar to those CCConcorde facilitates across its member network.
• Ramsay Santé: Largest private hospital group in France with significant oncology presence across multiple regions; comparable as a multi-site French healthcare provider delivering cancer services coordinated within regional 3C and Cancéropôle ecosystems.
• Centre Léon Bérard: Comprehensive cancer center in Lyon, member of UNICANCER, delivering multidisciplinary cancer care across the Auvergne-Rhône-Alpes region; comparable as a non-profit oncology institution operating within a regional coordination framework analogous to CCConcorde.

Direct peers

• UNICANCER: Federation of the 18 French Comprehensive Cancer Centers (CLCCs); comparable because it operates as a national-level coordination body for cancer care, sharing CCConcorde's mission of unifying multidisciplinary oncology practice across member institutions under defined quality standards.
• Cancéropôle Île-de-France: Regional cancer research and coordination network for the Île-de-France region; relevant because it performs a similar cancer coordination role at a regional scale, including clinical research facilitation and stakeholder convening across Paris-area institutions.
• Cancéropôle Grand Ouest: Regional cancer research pole covering western France; comparable because it performs a similar coordination and clinical research facilitation role across multiple cancer care sites at regional scale, paralleling CCConcorde's role in organizing oncology stakeholders.
• Cancéropôle PACA: Regional cancer research pole for Provence-Alpes-Côte d'Azur; comparable as another French regional coordination structure that parallels CCConcorde's role in organizing oncology stakeholders and clinical research across multi-establishment networks.
• Cancéropôle CLARA: Regional cancer research pole for the Auvergne-Rhône-Alpes region; comparable as a regional coordination structure focused on oncology, performing a network convening role analogous to CCConcorde but at a different territorial scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/ccconcorde

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CCConcorde